G C White 2nd
Overview
Explore the profile of G C White 2nd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
1516
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brackmann H, White 2nd G, Berntorp E, Andersen T, Escuriola-Ettingshausen C
Haemophilia
. 2018 Mar;
24 Suppl 3:3-14.
PMID: 29543371
Development of inhibitory antibodies to infused factor VIII (FVIII) concentrates continues to be the most serious complication of haemophilia A management. Induction of immune tolerance by administering high doses of...
2.
White 2nd G, Blatt P
J Thromb Haemost
. 2017 Nov;
15(12):2468-2470.
PMID: 29152851
No abstract available.
3.
White 2nd G, Francis C
J Thromb Haemost
. 2015 Jun;
13(7):1354-7.
PMID: 26095865
No abstract available.
4.
5.
Wang Z, Holly S, Larson M, Liu J, Yuan W, Chrzanowska-Wodnicka M, et al.
J Thromb Haemost
. 2009 Feb;
7(4):693-700.
PMID: 19192113
Background: The platelet alpha2beta1 integrin functions as both an adhesion and signaling receptor upon exposure to collagen. Recent studies have indicated that alpha2beta1 function can be activated via inside-out signaling,...
6.
White 2nd G, Rompietti R
J Thromb Haemost
. 2007 Sep;
5(10):2006-8.
PMID: 17883697
No abstract available.
7.
8.
White 2nd G, Kempton C, Grimsley A, Nielsen B, Roberts H
J Thromb Haemost
. 2005 Aug;
3(8):1676-81.
PMID: 16102033
Advances in molecular immunology over the past two decades permit a better understanding of why antibodies develop to peptide antigens like factor VIII and the events that lead to the...
9.
White 2nd G, Roberts H
J Thromb Haemost
. 2005 Jun;
3(6):1312.
PMID: 15946222
No abstract available.
10.
Kessler C, Gill J, White 2nd G, Shapiro A, Arkin S, Roth D, et al.
Haemophilia
. 2005 Apr;
11(2):84-91.
PMID: 15810908
Background: Deletion of the B-domain of recombinant blood coagulation factor VIII (BDDrFVIII) increases the manufacturing yield of the product but does not impair in vitro or in vivo functionality. BDDrFVIII...